Diabetes Treatments and Moral Hazard
University of Pennsylvania Law School; Erasmus School of Law; PERC - Property and Environment Research Center
George Mason University - Buchanan Center Political Economy; CESifo (Center for Economic Studies and Ifo Institute); Harvard University - Edmond J. Safra Center for Ethics
Journal of Law and Economics, Vol. 50, p. 519, 2007
FSU College of Law, Law and Economics Paper No. 05-21
FSU College of Law, Public Law Research Paper No. 159
In the face of rising diabetes rates, many states passed laws requiring health insurance plans to cover medical treatments for the disease. Although supporters of the mandates expect them to improve the health of diabetics, they have the potential to generate a moral hazard to the extent that medical treatments might displace individual behavioral improvements. Another possibility is that the mandates do little to improve insurance coverage for most individuals, as previous research on benefit mandates has suggested that often mandates duplicate what plans already cover. To examine the effects of these mandates, we employ a triple differences methodology comparing the change in the gap in body mass index (BMI) between diabetics and non-diabetics in mandate and non-mandate states. We find that mandates do generate a moral hazard problem with diabetics exhibiting higher BMIs after the adoption of these mandates.
Number of Pages in PDF File: 20
Keywords: Insurance, Mandates, Obesity, Offsetting Behavior
JEL Classification: I12, I18, J32, J38Accepted Paper Series
Date posted: July 23, 2005 ; Last revised: January 29, 2010
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo1 in 0.390 seconds